Abstract
Multiple myeloma is characterized by the malignant proliferation of plasma cells, causing extensive skeletal osteolytic destruction, osteopenia, and pathologic fractures. Bone scintigraphy is unsuitable for assessing multiple myeloma due to its osteolytic nature. However, multiple myeloma can occasionally be encountered on bone SPECT/CT studies performed for other indications. This chapter describes the features of myeloma on bone SPECT/CT, illustrated with a case where multiple myeloma was suspected in a patient referred for low back pain.
This is a preview of subscription content, log in via an institution to check access.
References
Chua S, Gnanasegaran G, Cook GJ. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases. Semin Nucl Med. 2009;39(6):416–30.
Couriel DR, Ricker H, Steinbach M, Lee CJ. Neurologic manifestations of blood dyscrasias. Hematol Oncol Clin North Am. 2016;30(4):723–31.
Dimopoulos M, Terpos E, Comenzo RL, Tosi P, Beksac M, Sezer O, et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia. 2009;23(9):1545–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Van den Wyngaert, T. (2023). Tumors: Multiple Myeloma. In: Van den Wyngaert, T., Gnanasegaran, G., Strobel, K. (eds) Clinical Atlas of Bone SPECT/CT. Springer, Cham. https://doi.org/10.1007/978-3-031-26449-8_115
Download citation
DOI: https://doi.org/10.1007/978-3-031-26449-8_115
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-26448-1
Online ISBN: 978-3-031-26449-8
eBook Packages: MedicineReference Module Medicine